The effect of oxytocin and Kisspeptin-10 in ovary and uterus of ischemia-reperfusion injured rats.
Aslan. M M; Erkanli Senturk. G G; Akkaya. H H; Sahin. S S; Yılmaz. B B
Key Findings
- Ischemia-reperfusion caused clear cellular damage in rat ovary and uterus.
- Pre‑treatment with oxytocin or kisspeptin-10 reduced tissue damage and lowered malondialdehyde (MDA) levels.
- Both peptides increased antioxidant markers (superoxide dismutase activity and glutathione levels).
- Combining oxytocin with kisspeptin did not provide extra benefit over oxytocin alone.
Practical Outcomes
- The results hint that oxytocin and kisspeptin-10 might act as antioxidants in reproductive tissues, but the study is limited to rats and uses a specific injury model. No human dosing or safety data are provided, so biohackers should view this as early, exploratory evidence rather than a ready‑to‑use protocol.
Summary
In a rat study, giving oxytocin or a short form of kisspeptin (kisspeptin-10) before a brief loss of blood flow to the ovaries and uterus helped protect those organs from damage. The treatment lowered markers of oxidative stress and boosted the organs' natural antioxidant defenses.
Abstract
Ischemia/reperfusion (I/R) injuries result in damage to endothelial and parenchymal cells. Oxytocin (OXY) stimulates uterine contraction during parturition and myoepithelial cells during suckling. OXY has been used as a protective antioxidant. Kisspeptin plays a key role in the central control of reproductive functions and onset of puberty. Recent studies show that these reproductive hormones have protective potential as antioxidant. The aim of this study is to investigate the potential protective effects of Kisspeptin and OXY as antioxidants on I/R injured ovary and uterus of female rats. Rats were separated into five groups. Group 1, is control group; Group 2, rats were subjected to ischemia followed by reperfusion. Group 3, OXY administration 30 min prior to I/R applied rats; Group 4, Kisspeptin administration 30 min prior to I/R applied rats; Group 5, OXY and Kisspeptin administration 30 min prior to I/R. Ovary and uterus were removed for histopathological and biochemical observations. Malondialdehyde, glutathione levels, and superoxide dismutase activities were analyzed in order to observe antioxidant potential of OXY and Kisspeptin. Hematoxylin and Eosin staining was applied for histopathologic scoring. Stromal and granulosa cells in ovary, endometrial cells in uterus were damaged in I/R group. The cellular damage of ovary and uterus were reduced in OXY and Kisspeptin administered I/R group when compared to only Kisspeptin injected I/R group and I/R group. There is no significant difference between OXY and OXY + Kisspeptin injected I/R groups. MDA levels were decreased in Kisspeptin and/or Oxytocin applied I/R group compared to I/R group. SOD activity and GSH levels were increased in Kisspeptin and/or OXY applied I/R group compared to I/R group. The present results suggest that exogenous application of oxytocin and kisspeptin can have antioxidant effects on the uterus and ovary.
Study Information
pubmed
2017
2017-08-01T00:00:00.000Z
10.1016/j.tjog.2016.12.018
49
23